(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

360 HCP

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

360 HCP

ST13

US500000079149276

Classe

1, 9, 42

Pedido

79149276

Registro

4693878

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

43

Atualização mais recente

24/02/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 9, 42

Data de depósito

30/01/2014

Data de registro

03/03/2015

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/06/2025

Última transação

24/02/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Berlin, DE

Examinador

WEIGLE, KATHERINE CONNOLLY

Localização atual

Historical data usage

Titulares e representantes

Titulares

BioGenes GmbH

Representantes

Bruce S. Londa Norris McLaughlin P.A.

Classificação técnica

Classes Nice

Classe 1Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

[ Chemicals and chemical preparations for industrial and scientific use; ] in-vitro diagnostic preparations used in science, in particular for industrial and scientific use; chemical test kits, consisting of immunological or marked antibodies and related reagents on serological and immunogenic basis and reagents therefor for quality control analysis of biological pharmaceutics for laboratory or research use; reagent kits comprised of reagents for scientific or research purposes for conducting the enzyme-linked immune adsorption test (ELISA) not for medical or veterinary purposes; [ chemical preparations for scientific purposes in form of buffers, salts, solvents and reactants for the afore-mentioned test kits; ] chemical reagents for non-medical purposes for buffer solutions used in assay kits; antibody solutions and conjugates and derivatives made from them, namely, biochemical for in vitro and in vivo scientific use; biochemical reagents for use in laboratories [ ; chemical, biochemical or biological preparations and chemical reagents and kits made thereof for the detection of cancer conditions, neoplastic conditions, inflammation conditions, infection conditions, degenerative conditions, genetically abnormal or morbid conditions, proliferative abnormal or morbid conditions, vascular diseases, premalignant conditions, malignant conditions, cancer and congenital defects, all for scientific and research purposes ]

Classe 9

Laboratory equipment, namely, antibody-coated laboratory worktops and microtiter plates, in particular for specifying cell type

Classe 42

[ Services of a biologist, chemistry or biochemistry services, namely, biochemical research and development, custom design and development of biochemical assays; services of a bacteriological, molecular-biological or chemical laboratory, namely, research and testing and scientific laboratory services; research, development and corresponding consultancy in the field of diagnostics, in particular product development of reagents and test kits, in particular on serological and immunogenic basis for the chemistry, biochemistry, bacteriology and biotechnology fields; conducting scientific testing and analysis in the field of virus diagnostics for determining contaminations in the production of active substances; development of testing methods and test kits for the chemistry, biochemistry, bacteriology and biotechnology fields; services in the field of technical and scientific supports, namely, scientific testing of immunoassays for determining contaminations of biological active substances and related diagnostic services in the field of research related thereto; biotechnological services, namely, research and development in the biotechnology field; consultancy relating to chemical and pharmaceutical research, consultancy relating to the development of diagnostic tests and procedures for the chemistry, biochemistry, bacteriology and biotechnology fields ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

43 publicações encontradas

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

23/02/2026

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

23/06/2025

71AG

REGISTERED-SEC.71 ACCEPTED

23/06/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

18/06/2025

ES71

TEAS SECTION 71 RECEIVED

05/03/2025

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

03/03/2024

RNWL

INTERNATIONAL REGISTRATION RENEWED

01/02/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

05/06/2022

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

05/04/2022

INPC

INVALIDATION PROCESSED

04/04/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

17/11/2021

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

17/03/2021

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

17/03/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

16/03/2021

ES71

TEAS SECTION 71 RECEIVED

12/02/2021

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

03/03/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/02/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

17/07/2015

FICS

FINAL DISPOSITION NOTICE SENT TO IB

30/06/2015

FIMP

FINAL DISPOSITION PROCESSED

30/06/2015

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/06/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

03/03/2015

GPNX

NOTIFICATION PROCESSED BY IB

19/12/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

16/12/2014

PUBO

PUBLISHED FOR OPPOSITION

16/12/2014

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/12/2014

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/12/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/11/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/11/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

31/10/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/10/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/10/2014

ALIE

ASSIGNED TO LIE

27/10/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

22/10/2014

RFNT

REFUSAL PROCESSED BY IB

22/08/2014

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/08/2014

RFRR

REFUSAL PROCESSED BY MPU

01/08/2014

MAFR

APPLICATION FILING RECEIPT MAILED

01/08/2014

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

31/07/2014

CNRT

NON-FINAL ACTION WRITTEN

30/07/2014

DOCK

ASSIGNED TO EXAMINER

28/07/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/07/2014

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

21/07/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace 360 HCP ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.